Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research note published on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $380.00 price objective on the pharmaceutical company’s stock. A number of other brokerages also recently issued reports on VRTX. HC Wainwright raised their price target […]
More Stories
Friedenthal Financial Purchases New Shares in Planet Fitness, Inc. (NYSE:PLNT)
Friedenthal Financial acquired a new stake in shares of Planet Fitness, Inc. (NYSE:PLNT – Free Report) in the 3rd quarter,...
23,473 Shares in Box, Inc. (NYSE:BOX) Purchased by Friedenthal Financial
Friedenthal Financial purchased a new stake in shares of Box, Inc. (NYSE:BOX – Free Report) in the third quarter, according...
Friedenthal Financial Purchases Shares of 3,152 Universal Health Services, Inc. (NYSE:UHS)
Friedenthal Financial acquired a new position in shares of Universal Health Services, Inc. (NYSE:UHS – Free Report) during the third...
Friedenthal Financial Has $2.76 Million Stock Holdings in Invesco S&P 500 Equal Weight Utilities ETF (NYSEARCA:RSPU)
Friedenthal Financial boosted its position in shares of Invesco S&P 500 Equal Weight Utilities ETF (NYSEARCA:RSPU – Free Report) by...
Friedenthal Financial Invests $760,000 in Brixmor Property Group Inc. (NYSE:BRX)
Friedenthal Financial bought a new stake in Brixmor Property Group Inc. (NYSE:BRX – Free Report) in the 3rd quarter, according...
TPG (NASDAQ:TPG) vs. Fifth Street Asset Management (OTCMKTS:FSAM) Critical Contrast
Fifth Street Asset Management (OTCMKTS:FSAM – Get Free Report) and TPG (NASDAQ:TPG – Get Free Report) are both finance companies,...